Citation Impact

Citing Papers

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids
2005
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Colchicine today
2006
Oral Anticoagulant Therapy
2012 Standout
Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation
2008 Standout
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism
2002
Internet Marketing of Herbal Products
2003
Gout
2016 Standout
CYP2C19 Polymorphism and Proton Pump Inhibitors
2004
Effect of age on the profile of alkanes in normal human breath
2000
Colchicine: Its mechanism of action and efficacy in crystal-induced inflammation
2008
Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials
2015 Standout
Novel evidence‐based colchicine dose‐reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P‐glycoprotein inhibitors
2011
Epidemiology of nasopharyngeal carcinoma
2002 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
2014
Concise Review: Clinical Relevance of Drug–Drug and Herb–Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein)
2007
The Enigmatic Epidemiology of Nasopharyngeal Carcinoma
2006 Standout
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
2015 Standout
Suspected Methotrexate Toxicity From Omeprazole
2012
Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma.
1999
Omeprazole
2010
Accumulating Evidence for a Drug–Drug Interaction Between Methotrexate and Proton Pump Inhibitors
2012
Applications of LC-MS to quantitation and evaluation of the environmental fate of chiral drugs and their metabolites
2008
Gout
2021 Standout
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout

Works of Uwe Tröger being referenced

Validity of advertising claims for multivitamin preparation Vitacor 20/90 on the internet
1998
Tetraparesis associated with colchicine is probably due to inhibition by verapamil of the P-glycoprotein efflux pump in the blood-brain barrier
2005
Severe myalgia from an interaction between treatments with pantoprazole and methotrexate
2002
Enantioselective quantification of omeprazole and its main metabolites in human serum by chiral HPLC–atmospheric pressure photoionization tandem mass spectrometry
2007
Intravenous colistin in a patient with serious burns and borderline syndrome: The benefits of therapeutic drug monitoring
2013
Adverse nondrug reactions: An update*
1996
Drug points: Ocular damage associated with proton pump inhibitors: Table 1
1997
Influence of Endogenous and Exogenous Effectors on the Pharmacokinetics of Theophylline
1995
Rankless by CCL
2026